SCHEMBL1664378

SCHEMBL1664378

CCCCCC(CCC)COC(=O)C1CCCCC1C(=O)OC(C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
CTSK P43235 2/20 0.39
ALDH1A1 P00352 4/20 0.38
CA2 P00918 1/20 0.38
CYP3A4 P08684 1/20 0.38
GPR88 Q9GZN0 2/20 0.36
CHRM3 P20309 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
LMNA P02545 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665834 0.91 ALDH1A1 (0.49) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1664082 0.90 PRSS1 (0.41) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1665255 0.88 PRSS1 (0.38) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1663826 0.88 PRSS1 (0.40) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1663766 0.84 PRSS1 (0.44) PRSS1PRSS2PRSS3ALDH1A1CA2
SCHEMBL1665337 0.83 CHRM2 (0.44) CTSKCYP3A4CHRM3KDM4ECHRM2
SCHEMBL1296685 0.83 PRSS1 (0.35) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1296707 0.83 PRSS1 (0.40) PRSS1PRSS2PRSS3ALDH1A1CA2
SCHEMBL1664112 0.82 PRSS1 (0.37) PRSS1PRSS2PRSS3CTSKALDH1A1
SCHEMBL1296709 0.81 PRSS1 (0.36) PRSS1PRSS2PRSS3ALDH1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC PRSS1 4807/4885PRSS2 4447/4885PRSS3 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.